Evidence map›Paper›PMID 35335742›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Gold Nanorod Substrate for Rat Fetal Neural Stem Cell Differentiation into Oligodendrocytes.

Krishna Deo Sharma, Karrer M Alghazali, Rabab N Hamzah, Sahitya Chetan Pandanaboina, Zeid A Nima Alsudani, Malek Muhi, Fumiya Watanabe, Guo-Lei Zhou, Alexandru S Biris, Jennifer Yanhua Xie

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Repurposing medications to prevent psychosis.Npj mental health research · 2025
    Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Krishna Deo SharmaMolecular Biosciences Graduate Program, Arkansas State University, State University, AR 72467, USA.ORCID 0000-0002-7724-3452
Karrer M AlghazaliCenter for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, AR 72204, USA.
Rabab N HamzahCenter for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, AR 72204, USA.
Sahitya Chetan PandanaboinaArkansas Biosciences Institute, Arkansas State University, Jonesboro, AR 72401, USA.
Zeid A Nima AlsudaniCenter for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, AR 72204, USA.
Malek MuhiCenter for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, AR 72204, USA.
Fumiya WatanabeCenter for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, AR 72204, USA.
Guo-Lei ZhouMolecular Biosciences Graduate Program, Arkansas State University, State University, AR 72467, USA.
Alexandru S BirisCenter for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, AR 72204, USA.
Jennifer Yanhua XieMolecular Biosciences Graduate Program, Arkansas State University, State University, AR 72467, USA.
University of Arkansas at Little Rock · USArkansas State University · US

Funding

Commercialization Readiness for Bone Filler Scaffold Device to Aid in Dental Applications and ReconstructionSB1DE028213 · NIDCR · NUSHORES BIOSCIENCES, LLC · PI ALGHAZALI, KARRER, BALLARD, SHARON C · 2021 to 2023
$3.0M
Feasibility study of a nanostructural system for bone regeneration in preparation for dental implantsR44DE028213 · NIDCR · NUSHORES BIOSCIENCES, LLC · PI LAM, DAVID K, SRIVATSAN, MALATHI · 2018 to 2020
$2.0M
Mechanistic Assessment of Osteopathic Manipulation inRelieving Migraine Headache Using a Novel Translational Rodent ModelR15AT011097 · NCCIH · NEW YORK INST OF TECHNOLOGY · PI XIE, YANHUA · 2020 to 2020
$428k
National Science Foundation 1457888NCCIH NIH HHS R15 AT011097NIDCR NIH HHS R44 DE028213NIDCR NIH HHS SB1 DE028213
6 · The paper itself

Abstract

Gold nanorods (AuNRs) have been proposed to promote stem cell differentiation in vitro and in vivo. In this study, we examined a particular type of AuNR in supporting the differentiation of rat fetal neural stem cells (NSCs) into oligodendrocytes (ODCs). AuNRs were synthesized according to the seed-mediated method resulting in nanorods with an aspect ratio of around 3 (~12 nm diameter, 36 nm length) and plasmon resonance at 520 and 780 nm, as confirmed by transmission electron microscopy (TEM) and UV-vis spectroscopy, respectively. A layer-by-layer approach was used to fabricate the AuNR substrate on the functionalized glass coverslips. NSCs were propagated for 10 days using fibroblast growth factor, platelet-derived growth-factor-supplemented culture media, and differentiated on an AuNR or poly-D-lysine (PDL)-coated surface using differentiation media containing triiodothyronine for three weeks. Results showed that NSCs survived better and differentiated faster on the AuNRs compared to the PDL surface. By week 1, almost all cells had differentiated on the AuNR substrate, whereas only ~60% differentiated on the PDL surface, with similar percentages of ODCs and astrocytes. This study indicates that functionalized AuNR substrate does promote NSC differentiation and could be a viable tool for tissue engineering to support the differentiation of stem cells.

Indexed as

differentiationgold nanorodoligodendrocytesrat fetal neural stem cells

Identifiers

PMID35335742
PMCPMC8953860
OpenAlexW4221041060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.